QA: ARDELYX INC. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001437402_2023_ARDELYX_INC.pdf

Logs

Graph

Absolute values for 0001437402, ARDELYX INC.

  xvar xval
0 AssetsCurrent 153,603,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 1,223,000
3 remainder_Assets 35,240,000
4 LiabilitiesCurrent 65,603,000
5 LiabilitiesNoncurrent 14,880,000
6 remainder_Liabilities 11,254,000
7 CostOfGoodsAndServicesSold 4,117,000
8 SellingGeneralAndAdministrativeExpense 76,599,000
9 ResearchAndDevelopmentExpense 35,201,000
10 remainder_Expenses 5,081,000
11 remainder_Revenues 52,158,000
12 remainder_NetIncome 1,633,000
13 remainder_ComprehensiveNetIncome -48,000
  yvar yval
0 Assets 190,066,000
1 Liabilities 91,737,000
2 Expenses 120,998,000
3 Revenues 52,158,000
4 StockholdersEquity 98,329,000
5 NetIncome -67,207,000
6 ComprehensiveNetIncome -67,231,000
7 BaseVar 228,320,000
8 EconomicCapitalRatio 0.723

Edgar->Model Mapping

Feature Distribution

Change over Time